Tonix Pharmaceuticals Enters into Agreement to Acquire Two FDA-Approved, Marketed Migraine Products from Upsher-Smith Laboratories, LLC

Zembrace® SymTouch® (sumatriptan injection) and Tosymra® (sumatriptan nasal spray) are indicated for the treatment of acute migraine in adults. Strategic acquisition helps build Tonix’s commercial capabilities and infrastructure ahead of potential launch of TNX-102 SL for the treatment of fibromyalgia.